BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Press Releases

  U.S. FDA Approves LEQSELVI™ (deuruxolitinib), an Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata

  July 26, 2024

   · 

  11 min read
• Press Releases

  Poolbeg Pharma PLC Announces Voluntary Delisting from OTCQB Market

  July 26, 2024

   · 

  2 min read
• Press Releases

  Ipsen receives CHMP positive opinions for Iqirvo® (elafibranor) in Primary Biliary Cholangitis and Kayfanda® (odevixibat) in Alagille Syndrome, two rare cholestatic liver diseases

  July 26, 2024

   · 

  17 min read
• Press Releases

  Avantor® Reports Second Quarter 2024 Results

  July 26, 2024

   · 

  19 min read
• Press Releases

  Chemomab Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement

  July 26, 2024

   · 

  6 min read
• Press Releases

  GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis

  July 26, 2024

   · 

  5 min read
• Press Releases

  Genetic Technologies Strategic Restructure Driving USA Sales Growth

  July 26, 2024

   · 

  7 min read
• Press Releases

  OmniGuide Holdings Announces Successful Completion of Patient Study for Revolutionary iSTONE(TM) Laser-Guided Lithotripsy Technology

  July 26, 2024

   · 

  2 min read
• Press Releases

  CStone Announces European Commission Approval of Sugemalimab (Cejemly®) as First-Line Treatment for Non-Small Cell Lung Cancer

  July 26, 2024

   · 

  10 min read
• Press Releases

  Marvel Biosciences Announces Stock Option Grants

  July 26, 2024

   · 

  3 min read